King Wealth Management Group’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-16,000
| Closed | -$20K | – | 151 |
|
|
2023
Q3 | $20K | Hold |
16,000
| – | – | ﹤0.01% | 144 |
|
|
2023
Q2 | $5K | Hold |
16,000
| – | – | ﹤0.01% | 150 |
|
|
2023
Q1 | $7K | Hold |
16,000
| – | – | ﹤0.01% | 148 |
|
|
2022
Q4 | $8K | Hold |
16,000
| – | – | ﹤0.01% | 141 |
|
|
2022
Q3 | $12K | Hold |
16,000
| – | – | ﹤0.01% | 151 |
|
|
2022
Q2 | $18K | Hold |
16,000
| – | – | ﹤0.01% | 159 |
|
|
2022
Q1 | $33K | Buy |
+16,000
| New | +$33K | 0.01% | 169 |
|
|
2021
Q3 | – | Sell |
-16,000
| Closed | -$85K | – | 186 |
|
|
2021
Q2 | $85K | Hold |
16,000
| – | – | 0.02% | 170 |
|
|
2021
Q1 | $74K | Hold |
16,000
| – | – | 0.02% | 159 |
|
|
2020
Q4 | $53K | Buy |
+16,000
| New | +$53K | 0.01% | 153 |
|